Royce & Associates LP Repligen Corp Transaction History

Royce & Associates LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$154.26 - $198.1 $12.6 Million - $16.2 Million	-81,700 Reduced 88.38%	10,739 $1.81 Million
Q4 2022 May 23, 2023	BUY	$162.42 - $220.56 $13.3 Million - $18 Million	81,700 Added 760.78%	92,439 $15.7 Million
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $1.24 Million - $1.69 Million	-7,655 Reduced 7.65%	92,439 $15.7 Million
Q3 2022 Nov 03, 2022	SELL	$160.42 - $256.21 $4.35 Million - $6.95 Million	-27,125 Reduced 21.32%	100,094 $18.7 Million
Q2 2022 Aug 04, 2022	BUY	$140.68 - $188.02 $5.21 Million - $6.96 Million	37,019 Added 41.04%	127,219 $20.7 Million
Q1 2022 May 05, 2022	BUY	$161.19 - $257.96 $14.5 Million - $23.3 Million	90,200 New	90,200 $17 Million
Q2 2019 Aug 12, 2019	SELL	$54.2 - $85.95 $27,208 - $43,146	-502 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$49.45 - $62.8 $7,170 - $9,106	145 Added 40.62%	502 $30,000
Q4 2018 Feb 11, 2019	SELL	$48.26 - $68.88 $1.31 Million - $1.87 Million	-27,096 Reduced 98.7%	357 $19,000
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $4,960 - $6,250	106 Added 0.39%	27,453 $1.52 Million
Q2 2018 Aug 09, 2018	BUY	$35.26 - $47.04 $3,455 - $4,609	98 Added 0.36%	27,347 $1.29 Million
Q1 2018 May 14, 2018	SELL	$30.92 - $37.27 $61 - $74	-2 Reduced 0.01%	27,249 $986,000
Q4 2017 Feb 09, 2018	SELL	$32.53 - $38.92 $1.72 Million - $2.06 Million	-52,898 Reduced 66.0%	27,251 $989,000
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $375,310 - $467,462	10,149 Added 14.5%	80,149 $3.07 Million
Q2 2017 Aug 07, 2017	BUY	N/A	70,000	70,000 $2.9 Million

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.